Oxcarbazepine is a neurological agent indicated for the treatment of both focal and generalized epileptic seizures. Clinically, it serves as a primary alternative to carbamazepine for patients who have exhibited hypersensitivity reactions to the latter.

AccuSift provides high-performance competitive antibody pairs for oxcarbazepine detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: ELISA LOD: 0.35 ng/mL